Trends in medical radionuclides
The biggest difficulty in the development of new radiomedical products is the process to produce radionuclides. Therefore, the development phase for medical research needs to be facilitated. Some innovative strategies, such as PRISMAP, are presented in this presentation and how they affect ongoing research across Europe and beyond.